Cerebrolysin®
Neuropeptide Preparation | Neurological Recovery
DoseGear research brief
Standardized neuropeptide preparation containing bioactive peptides and amino acids exhibiting neurotrophic and neuroprotective properties for stroke recovery, traumatic brain injury, and cognitive enhancement. Used clinically in 50+ countries.
IV/IM administration provides optimal bioavailability and brain penetration of neuropeptides and neurotrophic factors.
Compound background
Study windows describe what researchers measured, not when an individual should expect a result.
Standardized animal-derived peptide and amino-acid preparation, not one defined peptide.
Stroke, traumatic brain injury, and dementia research with proposed neurotrophic and neuroprotective activity.
A cited TBI trial used an initial 10-day course plus later cycles; a dementia meta-analysis assessed outcomes at four weeks and six months.
Reference data
Not personalized dosing instructions
Only injectable vial references are shown. Nasal, topical, and unsupported non-vial schedules are excluded.
| Research context | Amount | Frequency | Route |
|---|---|---|---|
| Acute Stroke | 20-50mL | Once daily for 10-21 days | IV infusion (diluted to 100mL minimum) |
| Traumatic Brain Injury | 20-50mL | Once daily for 7-30 days | IV infusion (diluted to 100mL minimum) |
| Alzheimer's Disease | 10-30mL | 5 days weekly for 4 weeks | IV injection/infusion (2-4 cycles yearly) |
| Vascular Dementia | 10-30mL | 5 days weekly for 4 weeks | IV injection/infusion (2-4 cycles yearly) |
Reference cycle
7-30 days depending on condition (stroke/TBI 10-30 days, dementia 4 weeks)
Reference storage
Room temperature ≤25°C, protected from light in original carton - never freeze
Efficacy and Safety of Cerebrolysin in Neurorecovery After Moderate-Severe Traumatic Brain Injury: Results from the CAPTAIN II Trial
Safety and Efficacy of Cerebrolysin in Early Post-Stroke Recovery: A Meta-Analysis of Nine Randomized Clinical Trials
Cerebrolysin for Functional Recovery in Patients with Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
This DoseGear profile combines published scientific literature with lyophilized-vial protocol references. Citations are provided for independent review.
